Trade ICCM anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
IceCure Medical Ltd. (ICCM) is trading at US$2.23, up 1.36% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$8.33M. Over the past 52 weeks, ICCM has traded between US$2.12 and US$42.00. On Syfe you can trade ICCM with $0 commission and add it to your watchlist.
| Previous close | US$2.20 |
|---|---|
| Market cap | US$8.33M |
| 52-week range | US$2.12 – US$42.00 |
| Volume | 58.36K |
| Exchange | US |
Add to Watchlist
Set Price Alert
IceCure Medical Ltd.
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.
Year: 2013
IceCure Medical Files to Register Sale of 5.5 Million Shares by Armistice
Jun 25, 9:54 PM · MT Newswires
IceCure Medical Shares Jump After Update on Commercial Adoption of Breast Cancer Cryoablation Procedures
Jun 17, 6:09 PM · MT Newswires
IceCure Medical Ltd. (ICCM) stock is trading at US$2.23, +1.36% from the previous close of US$2.20.
The market cap for IceCure Medical Ltd. (ICCM) stock is approximately US$8.33M.
The 52-week high for IceCure Medical Ltd. (ICCM) stock is US$42.00.
The 52-week low for IceCure Medical Ltd. (ICCM) stock is US$2.12.
IceCure Medical Ltd. (ICCM) does not currently pay a dividend.
Stay on top of ICCM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
